Form 8-K PHARMACYCLICS INC For: Jul 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share
July 31, 2014 4:05 PM EDTPharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $113 million versus the consensus estimate of $95.88 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
... More